Literature DB >> 24079735

Apoptotic signal molecules in skin biopsies of cutaneous lupus erythematosus: analysis using tissue microarray.

Ferdinand Toberer1, Jaromir Sykora, Daniel Göttel, Wolfgang Hartschuh, Siegfried Werchau, Alexander Enk, Stefan Joos, Peter H Krammer, Annegret Kuhn.   

Abstract

Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease. Different pathogenetic mechanisms, including the accumulation of apoptotic keratinocytes in CLE, have been reported. Therefore, we investigated whether CLE and other inflammatory skin diseases differ with regard to the epidermal expression of molecules that are crucial for the initiation and regulation of apoptosis. In this study, 241 skin biopsies from patients with CLE, psoriasis (PSO), lichen planus (LP) and healthy controls (HCs) were analysed immunohistochemically using the tissue microarray (TMA) technique. The TUNEL assay and anti-activated caspase-3 antibodies revealed a significant increase of apoptotic keratinocytes in CLE lesions compared with HCs. Furthermore, we detected a significant increase in the epidermal expression of CD95 in CLE specimens compared with PSO, LP and HCs. These data suggest that the accumulation of apoptotic keratinocytes in CLE might be due to the increased epidermal expression of CD95, resulting in increased activity of the extrinsic apoptotic pathway in the disease.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CD95; apoptosis; cutaneous lupus erythematosus; tissue microarray

Mesh:

Substances:

Year:  2013        PMID: 24079735     DOI: 10.1111/exd.12216

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  11 in total

1.  Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Authors:  Purvi Mande; Bahar Zirak; Wei-Che Ko; Keyon Taravati; Karen L Bride; Tia Y Brodeur; April Deng; Karen Dresser; Zhaozhao Jiang; Rachel Ettinger; Katherine A Fitzgerald; Michael D Rosenblum; John E Harris; Ann Marshak-Rothstein
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 2.  Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Authors:  Joshua Chang; Victoria P Werth
Journal:  Expert Rev Clin Immunol       Date:  2016-06-01       Impact factor: 4.473

Review 3.  Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.

Authors:  Jasmine N Stannard; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 4.  [Lupus erythematosus].

Authors:  C Günther; S Beissert
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 5.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

Review 6.  Lupus erythematosus revisited.

Authors:  Annegret Kuhn; Joerg Wenzel; Marc Bijl
Journal:  Semin Immunopathol       Date:  2015-12-04       Impact factor: 11.759

Review 7.  Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review.

Authors:  Annegret Kuhn; Jörg Wenzel; Heiko Weyd
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 10.817

8.  Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature.

Authors:  Mohammad Shalbaf; Adewonuola A Alase; Anna Berekmeri; Md Yuzaiful Md Yusof; Jelena Pistolic; Mark J Goodfield; Sara Edward; Natalia V Botchkareva; Martin Stacey; Edward M Vital; Miriam Wittmann
Journal:  Lupus Sci Med       Date:  2019-07-14

Review 9.  Current concepts of photosensitivity in cutaneous lupus erythematosus.

Authors:  Benjamin Klein; Manfred Kunz
Journal:  Front Med (Lausanne)       Date:  2022-08-25

Review 10.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Jordan C Achtman; Victoria P Werth
Journal:  Arthritis Res Ther       Date:  2015-08-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.